# NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation- Treatment Use Study

> **NCT00721149** · PHASE3 · TERMINATED · sponsor: **Biosense Webster, Inc.** · enrollment: 10 (actual)

## Conditions studied

- Heart Diseases
- Arrhythmia
- Atrial Fibrillation

## Interventions

- **DEVICE:** Radiofrequency Ablation

## Key facts

- **NCT ID:** NCT00721149
- **Lead sponsor:** Biosense Webster, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-09
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Enrollment stopped after CDRH Advisory Panel (Nov 20, 2008) recommended NAVISTAR® THERMOCOOL® catheter approval.
- **Last updated:** 2025-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00721149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00721149, "NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation- Treatment Use Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00721149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*